Skip to main content
Amoy Diagnostics Co.,Ltd. logo

Amoy Diagnostics Co.,Ltd. — Investor Relations & Filings

Ticker · 300685 ISIN · CNE1000034D3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,090 across all filing types
Latest filing 2018-06-15 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 300685

About Amoy Diagnostics Co.,Ltd.

https://www.amoydx.com

Amoy Diagnostics Co., Ltd. specializes in the development and commercialization of molecular diagnostic products for precision oncology. The company provides a comprehensive portfolio of testing kits designed to identify genetic mutations and biomarkers essential for personalized cancer treatment. Its core technology platforms include the proprietary ADx-ARMS, Super-ARMS, and specialized Next-Generation Sequencing (NGS) solutions. AmoyDx focuses on companion diagnostics (CDx), collaborating extensively with global pharmaceutical companies to integrate diagnostic testing into clinical drug development and patient management. Key products cover a wide range of solid tumors, including lung, colorectal, and breast cancers, facilitating targeted therapy selection and monitoring. The company maintains rigorous quality standards, with numerous products receiving regulatory approvals for clinical use in multiple international markets.

Recent filings

Filing Released Lang Actions
关于使用闲置募集资金进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company regarding the progress and details of using idle raised funds for cash management, including information about investment products, returns, risk control measures, and approvals. It does not contain comprehensive financial statements or detailed financial performance data typical of an Annual Report or Interim Report. It is a specific update on financing activities related to the use of idle raised funds, which fits the category of Capital/Financing Update (CAP). The document length is about 4700 characters, which is sufficient for a detailed announcement but not a full financial report. Therefore, the classification is Capital/Financing Update (CAP).
2018-06-15 Chinese
2017年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a "2017 Annual General Meeting Resolution Announcement" from a company, detailing the resolutions passed at the shareholders' meeting held in 2018. It includes voting results on various agenda items such as the 2017 annual report, financial statements, profit distribution plan, amendments to the company charter, appointment of auditors, and credit facility applications. The document is primarily focused on announcing the voting results and resolutions from the AGM, rather than presenting the full annual report or financial statements themselves. The length is 4168 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2018-06-13 Chinese
2017年度股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the legality and compliance of the 2017 Annual General Meeting (AGM) of Xiamen Aide Biomedical Technology Co., Ltd. It details the convening, attendance, voting procedures, and results of the 2017 AGM. The document does not contain the actual annual report or financial statements but rather focuses on the legal validation of the AGM process and voting outcomes. This type of document is typically classified as Declaration of Voting Results & Voting Rights Announcements (DVA) because it reports official voting results from a shareholder meeting. The document length (6123 characters) and content confirm it is not merely an announcement of a report but a detailed legal opinion on the AGM proceedings and voting results.
2018-06-13 Chinese
关于使用闲置募集资金进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company regarding the progress of using idle raised funds for cash management, including details of financial products purchased, redemption, investment risks, approvals, and related procedures. It is not a full financial report but a specific update on the company's use of idle fundraising capital for cash management purposes. The document is relatively short (4538 characters) and focuses on a particular financing activity rather than comprehensive financial results or management discussion. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2018-06-05 Chinese
关于投资Universal Sequencing Technology Corporation的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by Xiamen Ed Biotechnology Co., Ltd. regarding an investment in Universal Sequencing Technology Corporation. It details the investment amount, share acquisition, rights attached to the preferred shares, transaction conditions, and risks involved. The document is a formal disclosure of a capital investment transaction, including financial data of the investee company and legal terms of the agreement. It does not contain financial statements or comprehensive financial performance data of the reporting company itself, nor is it a report or transcript. It is clearly an update on a financing activity involving share purchase and capital injection. Therefore, the document fits best under the category of Capital/Financing Update (CAP). The document length is 4616 characters, which is sufficient for a detailed announcement rather than a brief notice or a report publication announcement.
2018-05-23 Chinese
关于召开2017年度股东大会的通知
AGM Information Classification · 100% confidence The document is a detailed notice about the convening of the 2017 Annual General Meeting (AGM) of Xiamen Aide Bio-pharmaceutical Technology Co., Ltd. It includes information about the meeting date, location, agenda items (such as the 2017 annual report, financial statements, profit distribution plan, amendments to the articles of association, and appointment of auditors), voting procedures (both in-person and online), registration methods, and other logistical details. The document does not contain the actual annual report or financial statements but rather serves as a formal notification to shareholders about the upcoming AGM and the matters to be discussed and voted upon. This fits the definition of AGM Information (AGM-R), which includes presentations and materials shared during the Annual General Meeting or notices about it. The document length is about 4996 characters, which is consistent with a detailed meeting notice rather than a full annual report or financial filing. Therefore, the correct classification is AGM Information (AGM-R).
2018-05-23 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.